The WELLNET team as part of the Royal Free Hospital and University College London Cancer Institute have a large programme researching the cause of NETs, the genomic changes, as well as studies aimed at earlier diagnosis (e.g. circulating tumour cells and DNA) and development of new imaging modalities and therapies.
The team are involved in many clinical trials into NETs. If we thought it was appropriate to involve you in research studies we would happily discuss this with you. Research is core to our philosophy as this is how we can better personalise treatment as well as improve the longer term future of our patients.
The European Neuroendocrine Tumor Society offer further information on current trials throughout Europe and the US